Hatice Odabaş

485 total citations
59 papers, 325 citations indexed

About

Hatice Odabaş is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Hatice Odabaş has authored 59 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Oncology, 30 papers in Pulmonary and Respiratory Medicine and 14 papers in Surgery. Recurrent topics in Hatice Odabaş's work include HER2/EGFR in Cancer Research (13 papers), Colorectal Cancer Treatments and Studies (9 papers) and Breast Cancer Treatment Studies (9 papers). Hatice Odabaş is often cited by papers focused on HER2/EGFR in Cancer Research (13 papers), Colorectal Cancer Treatments and Studies (9 papers) and Breast Cancer Treatment Studies (9 papers). Hatice Odabaş collaborates with scholars based in Türkiye, Cambodia and Jordan. Hatice Odabaş's co-authors include Leyla Kılıç, İbrahim Yıldız, Faruk Taş, Fatma Şen, Serkan Keskın, Nurullah Zengin, Nuriye Özdemir, Berna Öksüzoğlu, Mahmut Gümüş and Doğan Uncu and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and The Oncologist.

In The Last Decade

Hatice Odabaş

50 papers receiving 321 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hatice Odabaş Türkiye 10 194 162 85 44 33 59 325
Muhammed Bülent Akıncı Türkiye 11 154 0.8× 101 0.6× 53 0.6× 39 0.9× 15 0.5× 49 342
Caroline J. Rieser United States 12 316 1.6× 131 0.8× 214 2.5× 57 1.3× 51 1.5× 30 452
Nebi Serkan Demirci Türkiye 10 160 0.8× 88 0.5× 72 0.8× 37 0.8× 33 1.0× 47 280
Shuichi Takano Japan 10 87 0.4× 150 0.9× 170 2.0× 41 0.9× 38 1.2× 55 408
Kotaro Kitani Japan 12 113 0.6× 128 0.8× 163 1.9× 32 0.7× 36 1.1× 45 366
Jukes P. Namm United States 13 240 1.2× 89 0.5× 157 1.8× 51 1.2× 33 1.0× 46 457
Ashley N. Krepline United States 8 311 1.6× 143 0.9× 130 1.5× 93 2.1× 103 3.1× 15 375
Andrei Manilchuk United States 9 242 1.2× 84 0.5× 219 2.6× 46 1.0× 56 1.7× 21 354
Otto van Delden Netherlands 14 141 0.7× 231 1.4× 197 2.3× 35 0.8× 74 2.2× 34 494
Mihir M. Shah United States 10 161 0.8× 161 1.0× 168 2.0× 38 0.9× 64 1.9× 68 369

Countries citing papers authored by Hatice Odabaş

Since Specialization
Citations

This map shows the geographic impact of Hatice Odabaş's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hatice Odabaş with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hatice Odabaş more than expected).

Fields of papers citing papers by Hatice Odabaş

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hatice Odabaş. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hatice Odabaş. The network helps show where Hatice Odabaş may publish in the future.

Co-authorship network of co-authors of Hatice Odabaş

This figure shows the co-authorship network connecting the top 25 collaborators of Hatice Odabaş. A scholar is included among the top collaborators of Hatice Odabaş based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hatice Odabaş. Hatice Odabaş is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dane, Faysal, Erdem Göker, Kazım Uygun, et al.. (2025). Regional and Gender-Based Distribution of KRAS Mutations in Metastatic Colorectal Cancer Patients in Turkey: An Observational Study. Medicina. 61(4). 694–694.
2.
Erman, Mustafa, et al.. (2025). Efficacy and Clinical Outcomes of Crizotinib in Patients with ROS1-Rearranged NSCLC: A Multicenter Study. Medicina. 61(3). 490–490. 1 indexed citations
3.
4.
5.
6.
Alan, Özkan, et al.. (2024). Prognostic Impact and Clinical Features of Spread through Air Spaces in Operated Lung Cancer: Real-World Analysis. Medicina. 60(8). 1374–1374. 4 indexed citations
7.
8.
Alan, Özkan, et al.. (2024). Evaluating the Effectiveness of Nivolumab in Metastatic Lung Cancer Among Patients Aged 65 and Older. Journal of Clinical Medicine. 13(20). 6263–6263. 1 indexed citations
9.
Alan, Özkan, et al.. (2024). The role of laboratory indices on treatment response and survival in breast cancer receiving neoadjuvant chemotherapy. Scientific Reports. 14(1). 12123–12123. 6 indexed citations
10.
Alan, Özkan, et al.. (2023). Outcomes of surveillance versus adjuvant treatment for patients with stage-I seminoma: a single-center experience. World Journal of Urology. 41(8). 2201–2207. 1 indexed citations
11.
12.
Odabaş, Hatice, et al.. (2023). Does Proton Pump Inhibitors Decrease the Efficacy of Palbociclib and Ribociclib in Patients with Metastatic Breast Cancer?. Medicina. 59(3). 557–557. 10 indexed citations
13.
Aksoy, Asude, Hatice Odabaş, Serap Kaya, et al.. (2017). Hormone receptor status and survival of medullary breast cancer patients. Saudi Medical Journal. 38(2). 156–162. 9 indexed citations
14.
Gümüş, Mahmut, Ahmet Bılıcı, Hatice Odabaş, et al.. (2016). Outcomes of surveillance versus adjuvant chemotherapy for patients with stage IA and IB nonseminomatous testicular germ cell tumors. World Journal of Urology. 35(7). 1103–1110. 8 indexed citations
15.
Odabaş, Hatice, Arife Ulaş, Mevlüde İnanç, et al.. (2015). Is second-line systemic chemotherapy beneficial in patients with non-small cell lung cancer (NSCLC)? A multicenter data evaluation by the Anatolian Society of Medical Oncology. Tumor Biology. 36(12). 9641–9648. 5 indexed citations
16.
Akıncı, Muhammed Bülent, Ali̇ İnal, Hatice Odabaş, et al.. (2013). Sequential adjuvant docetaxel and anthracycline chemotherapy for node positive breast cancers: a retrospective study.. PubMed. 18(2). 314–20. 2 indexed citations
17.
Midilli, Tülay Sağkal, et al.. (2013). Kırsal kesimde yaşayan yaşlı bireylerin tamamlayıcı ve alternatif tedavi yöntemlerini kullanma durumları. 27(1). 19–26. 7 indexed citations
18.
Taş, Faruk, Fatma Şen, Hatice Odabaş, et al.. (2012). Performance status of patients is the major prognostic factor at all stages of pancreatic cancer. International Journal of Clinical Oncology. 18(5). 839–846. 91 indexed citations
19.
Caner, Sedat, et al.. (2011). Gastric adenocarcinoma under the age of 40; more metastatic, less differentiated.. PubMed. 16(2). 253–6. 6 indexed citations
20.
Íkbal, Mevlit, et al.. (2004). Genotoxic Evaluation of the Antibacterial Drug, Ciprofloxacin, in Cultured Lymphocytes of Patients with Urinary Tract Infection. TURKISH JOURNAL OF MEDICAL SCIENCES. 34(5). 309–313. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Muhammed Bülent Akıncı Breakdown of academic impact, for papers by Caroline J. Rieser Breakdown of academic impact, for papers by Nebi Serkan Demirci Breakdown of academic impact, for papers by Shuichi Takano Breakdown of academic impact, for papers by Kotaro Kitani Breakdown of academic impact, for papers by Jukes P. Namm Breakdown of academic impact, for papers by Ashley N. Krepline Breakdown of academic impact, for papers by Andrei Manilchuk Breakdown of academic impact, for papers by Otto van Delden Breakdown of academic impact, for papers by Mihir M. Shah
Rankless by CCL
2026